Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (AVHHL) EBIT (2018 - 2025)

Historic EBIT for AVITA Medical (AVHHL) over the last 8 years, with Q4 2025 value amounting to -$10.4 million.

  • AVITA Medical's EBIT fell 452.95% to -$10.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$42.5 million, marking a year-over-year increase of 2483.88%. This contributed to the annual value of -$42.5 million for FY2025, which is 2484.23% up from last year.
  • As of Q4 2025, AVITA Medical's EBIT stood at -$10.4 million, which was down 452.95% from -$9.2 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's EBIT registered a high of -$4.7 million during Q2 2021, and its lowest value of -$17.2 million during Q1 2024.
  • In the last 5 years, AVITA Medical's EBIT had a median value of -$9.9 million in 2023 and averaged -$9.8 million.
  • As far as peak fluctuations go, AVITA Medical's EBIT skyrocketed by 6387.93% in 2021, and later crashed by 10773.53% in 2023.
  • AVITA Medical's EBIT (Quarter) stood at -$5.9 million in 2021, then rose by 0.69% to -$5.9 million in 2022, then tumbled by 107.74% to -$12.3 million in 2023, then increased by 18.87% to -$10.0 million in 2024, then dropped by 4.53% to -$10.4 million in 2025.
  • Its EBIT was -$10.4 million in Q4 2025, compared to -$9.2 million in Q3 2025 and -$11.1 million in Q2 2025.